Prolog Ventures Hl II

Venture Capital Exempt reporting adviser

Legal name: Prolog Ventures Hl II, LLC

St. Louis, MO Website LinkedIn X

AUM

$2.8M
Private fund assets

Private funds

1
Venture Capital 1

Private fund assets

$2.8M
Gross asset value

Employees

—

Last Form D raise

—

From SEC Form ADV filing (filed Mar 30, 2026). View on SEC

People(3)

Owners and executive officers named on the firm's SEC Form ADV.

B
Brian Clevinger
Managing Director
Source: SEC Form ADV
G
Greg Johnson
Trustee, Gregory R. Johnson Revocable Trust Dated July 29, 2002 AS Amended
Source: SEC Form ADV
I
Ilya Nykin
Managing Director
Source: SEC Form ADV

Funds(1)

Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.

FundTypeGross assetsRaised (Form D)InvestorsLast Form DRecency
Prolog Healthy Living Fund II, L.P.Venture Capital$2.8M———

Board seats(2)

Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.

Altheus Therapeutics
BiotechnologyOklahoma City, OKDirector: Brian Clevinger
$8.1M raised
Since Mar 2012
SEC Form D
Nest Collective
OtherEmeryville, CADirector: Ilya Nykin
$6.0M raised
Since Feb 2012
SEC Form D

Regulatory identifiers

CRD number
170338
SEC file number
802-79436

Sources